CClinicalTrials.gg
CompletedNCT02907892Updated Aug 17, 2018Results posted

Effect of Intra-operative Glove-changing During Cesarean Section on Post-op Complications: A Randomized Controlled Trial

An interventional study of Glove change in Wound Complications, sponsored by University of Minnesota. Completed at 1 site in United States. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-17.

Sponsored by University of Minnesota · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
554
Allocation
Randomized
Sex
Female
01

Study summary

A randomized controlled trial to determine whether changing of gloves by the surgical team during cesarean section may decrease post-operative infectious morbidity and wound complications

Read the detailed description

This was a randomized, single-blind controlled trial of women who underwent cesarean section at Healthpartners Regions Hospital. Potential participants were identified during routine obstetrical care of singleton pregnancies at Regions Hospital, at the time that cesarean section was decided as the route of delivery by patient and provider. Patients were excluded if the cesarean section was performed emergently. Randomization occurred in the operating room during preparation for cesarean section; nursing staff drew a computer generated allocation card from a stack placed within an envelope in the room. Patients assigned to the control group underwent cesarean section with standard surgical technique at the discretion of the attending surgeon. Patients assigned to the glove change group underwent cesarean section in which the surgical team - surgeon, assistant, and scrub nurse - replaced their outer surgical gloves with a new sterile pair of gloves prior to abdominal closure. Abdominal closure was considered to begin with closure of the peritoneum, if performed, otherwise with closure of the abdominal fascia.

02

Conditions studied

  • Wound Complications
03

In context

Postoperative Complications

1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.

This study's enrollment of 554 is above the median of 119 across 689 interventional studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.

Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Pregnant woman with singleton pregnancy and shared decision making with provider resulting in plan for cesarean section

Exclusion criteria

Exclusion Criteria:

  • Severe immunocompromise (AIDS) or emergent nature of cesarean section
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
554 participants (actual)

Study arms

  • No intervention
    Control

    Standard cesarean section surgical technique per surgeon preference

  • Experimental
    Glove Change

    Cesarean section including changing of sterile surgical gloves immediately prior to abdominal closure

    Procedure: Glove change

Interventions

  • ProcedureGlove change

    Intra-operative changing of sterile surgical gloves immediately prior to abdominal closure during cesarean section

06

What researchers measure

Primary outcomes

  1. Composite Wound Complication

    Occurence of at least one of the following: wound seroma, wound hematoma, wound infection, skin separation of at least 1cm, or other incisional separation or abnormality requiring a bedside procedure to fix

    Time frame: Within 8 weeks following cesarean section

07

Results

Posted Aug 17, 2018

Participant flow

Participant flow — Overall Study
MilestoneControlGlove Change
Started277276
Completed250236
Not completed2740
Withdrew: Lost to follow-up2740

Outcome measures

PrimaryComposite Wound Complication

Occurence of at least one of the following: wound seroma, wound hematoma, wound infection, skin separation of at least 1cm, or other incisional separation or abnormality requiring a bedside procedure to fix

Time frame:
Within 8 weeks following cesarean section
Reported as:
Count of participants · Participants
Composite Wound Complication
ParticipantsControlGlove Change
Composite Wound Complication3415

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Control—0/277 (0%)0/277 (0%)
Glove Change—0/276 (0%)0/276 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)ControlGlove ChangeTotal
Mean30.7 ± 5.330.6 ± 5.430.6 ± 5.3
Sex: Female, Male
Sex: Female, Male(Participants)ControlGlove ChangeTotal
Female277276553
Male000
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)ControlGlove ChangeTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)ControlGlove ChangeTotal
United States277276553
08

Study locations

1 site
  • Regions Hospital
    Saint Paul, Minnesota 55101, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 17, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02907892
Lead sponsor
University of Minnesota
Collaborators
HealthPartners Institute
Responsible party
Sponsor
First posted
Sep 20, 2016
Start date
Jul 2015
Primary completion
Nov 2016
Completion
Jan 2017
Results posted
Aug 17, 2018
Last update
Aug 17, 2018

Study contacts

Jonathan Scrafford, MD
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion